These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38302230)

  • 1. Acute promyelocytic leukaemia in low-income and middle-income countries: a Brazilian experience.
    Pereira-Martins DA; Weinhäuser I; Coelho-Silva JL; Ammatuna E; Huls G; Schuringa JJ; Rego EM; Lucena-Araujo AR
    Lancet Haematol; 2024 Feb; 11(2):e98-e99. PubMed ID: 38302230
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines.
    Jácomo RH; Melo RA; Souto FR; de Mattos ER; de Oliveira CT; Fagundes EM; Bittencourt HN; Bittencourt RI; Bortolheiro TC; Paton EJ; Bendlin R; Ismael S; Chauffaille Mde L; Silva D; Pagnano KB; Ribeiro R; Rego EM
    Haematologica; 2007 Oct; 92(10):1431-2. PubMed ID: 18024380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life with treated acute promyelocytic leukaemia.
    Rahman A
    Lancet Oncol; 2014 Nov; 15(12):e533. PubMed ID: 25602107
    [No Abstract]   [Full Text] [Related]  

  • 4. The apparent excess of acute promyelocytic leukemia in infant acute leukemias in Brazil.
    Mendes WL; Coser VM; Ramos G; Pereira W; Lopes LF; de Oliveira MS
    Haematologica; 2004 Nov; 89(11):ELT16. PubMed ID: 15533849
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating acute promyelocytic leukaemia in Latin America: lessons from the International Consortium on Acute Leukaemia experience.
    Corrêa de Araujo Koury L; Ganser A; Berliner N; Rego EM
    Br J Haematol; 2017 Jun; 177(6):979-983. PubMed ID: 28466545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].
    Haanen C; Vermes I
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1738-41. PubMed ID: 10494320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.
    Gillis JC; Goa KL
    Drugs; 1995 Nov; 50(5):897-923. PubMed ID: 8586032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
    Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF;
    Lancet Haematol; 2015 Sep; 2(9):e357-66. PubMed ID: 26685769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012.
    Thuler LCS; Pombo-de-Oliveira MS
    Ann Hematol; 2017 Mar; 96(3):355-362. PubMed ID: 27752823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tretinoin toxicity in children with acute promyelocytic leukaemia.
    Mahmoud HH; Hurwitz CA; Roberts WM; Santana VM; Ribeiro RC; Krance RA
    Lancet; 1993 Dec; 342(8884):1394-5. PubMed ID: 7901684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL).
    Rego EM; Kim HT; Ruiz-Argüelles GJ; Uriarte Mdel R; Jacomo RH; Gutiérrez-Aguirre H; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone C; Martinez L; Meillón LA; Gómez-Almaguer D; Kwaan H; Garcés-Eisele J; Gallagher R; Niemeyer CM; Lowenberg B; Ribeiro R; LoCoco F; Sanz MA
    Hematology; 2012 Apr; 17 Suppl 1():S36-8. PubMed ID: 22507775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History of promyelocytic leukaemia.
    Bernard J
    Leukemia; 1994; 8 Suppl 2():S1-5. PubMed ID: 7815829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study.
    Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; de Lourdes Chauffaille M; Chiattone CS; Lima AS; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
    Br J Haematol; 2014 Aug; 166(4):540-9. PubMed ID: 24796963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clustered incidence of adult acute promyelocytic leukemia in the vicinity of Baltimore.
    Li AY; Kashanian SM; Hambley BC; Zacholski K; Baer MR; Duong VH; El Chaer F; Holtzman NG; Norsworthy KJ; Levis MJ; Smith BD; Kamangar F; Ghiaur G; Emadi A
    Leuk Lymphoma; 2020 Nov; 61(11):2743-2747. PubMed ID: 32536282
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo evidence of all-trans retinoic acid inducing maturation in acute promyelocytic leukaemia.
    Hamidah HN; Cheong SK; Ainoon O
    Acta Haematol; 1993; 89(1):50-1. PubMed ID: 8480488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
    Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
    Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of relapsed/refractory acute promyelocytic leukaemia in children, adolescents and young adult patients - a 25-year Italian experience.
    Testi AM; Mohamed S; Diverio D; Piciocchi A; Menna G; Rizzari C; Timeus F; Micalizzi C; Lo Nigro L; Santoro N; Masetti R; Micheletti MV; Ziino O; Onofrillo D; Ladogana S; Putti C; Pierani P; Arena V; Zecca M; Foà R; Locatelli F
    Br J Haematol; 2021 Oct; 195(2):278-283. PubMed ID: 34145572
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicity of tretinoin in acute promyelocytic leukaemia.
    Yokokura M; Hatake K; Komatsu N; Kajitani H; Miura Y
    Lancet; 1994 Feb; 343(8893):361-2. PubMed ID: 7905175
    [No Abstract]   [Full Text] [Related]  

  • 19. Tailoring treatment strategy for acute promyelocytic leukemia in low-income countries.
    Rizzari C; Biondi A
    Pediatr Blood Cancer; 2009 Sep; 53(3):303-5. PubMed ID: 19544375
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment Outcomes Of Patients With Newly Diagnosed Acute Promyelocytic Leukemia; Experience From A Developing Country.
    Javed H; Chudary QU; Iftikhar R; Shahbaz N; Ali M; Hamayun S
    J Ayub Med Coll Abbottabad; 2022; 34(4):791-796. PubMed ID: 36566401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.